To Prove the Effectiveness of PENS Therapy With Peripheral Neuropathy

DyAnsys, Inc.1 site in 1 country66 target enrollmentApril 4, 2018

ConditionsPeripheral Neuropathy

Overview

Phase: N/A
Intervention: Not specified
Conditions: Peripheral Neuropathy
Sponsor: DyAnsys, Inc.
Enrollment: 66
Locations: 1
Primary Endpoint: Reduction of Neuropathy pain
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To prove the effectiveness of Percutaneous Electrical Neuro-stimulation therapy for the treatment of conditions associated with peripheral neuropathy, in a double-blind environment.

Registry

clinicaltrials.gov

Start Date

April 4, 2018

End Date

October 2018

Last Updated

7 years ago

Study Type

Interventional

Study Design

Factorial

Sex

All

Investigators

Sponsor

DyAnsys, Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients with Neuropathy pain

Exclusion Criteria

•Patient with inbuilt pacemakers or any other devices which allows current into the body, pregnant ladies.

Outcomes

Primary Outcomes

Reduction of Neuropathy pain

Time Frame: According to the patients condition and other factors expected to reduce pain in 4th week of the treatment

This treatments effective outcome will be, "Percutaneous Electrical Nerve Stimulation therapy will have the ability to reduce the pain and other conditions regarding peripheral neuropathy" which can be verified through "Biothesiometer" parameters.